Research Journal of Pharmacy and Technology

SCOPUS
  • Year: 2020
  • Volume: 13
  • Issue: 6

Amlodipine And Atenolol: Combination Therapy Versus Monotherapy In Reducing Blood Pressure -A Focus On Safety And Efficacy

  • Author:
  • Diksha Sharma1, Dinesh Kumar Mehta1, Karun Bhatti2, Rina Das1,, Ram Mohan Chidurala3
  • Total Page Count: 7
  • Page Number: 3007 to 3013

1M.M.College of Pharmacy, Maharishi Markandeshwar (Deemed to be) University, Mullana, Ambala, Haryana, India

2Department of Medicine, M.M. Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be) University, Mullana, Ambala, Haryana, India

3Hospitalist medicine physicians of Ohio, Mount Carmel East Hospital, 6001 E.broad street, Columbus, Ohio, USA

Abstract

Cardiovascular diseases are major public health challenge. Hypertension is among the most important modifiable risk-factors for cardiovascular diseases. Many placebo-controlled trials and meta-analysis study of antihypertensive medication have shown that such treatment can prevent and postpone myocardial infarction and stroke. Amlodipine and atenolol are widely used in the treatment of high blood pressure. Combining multiple classes of antihypertensive drugs together is one important practice for achieving blood pressure control in most hypertensive patients. Most of the benefits of combination therapy in comparison with monotherapy includes: a synergistic effect of each drug's therapeutic effects and reduction of side effects due to lower dose of each drug. Amlodipine with atenolol might bestow a good option for combining these two classes of agents with proven cardiovascular benefits for better blood pressure control. In this study we have reviewed the effect of combination of atenolol and amlodipine over monotherapy of amlodipine and atenolol in patients with mild-tomoderate hypertension.

Keywords

Amlodipine, Atenolol, Combination therapy, Hypertension, Monotherapy